Literature DB >> 11838073

[Prophylaxis against RS virus infection].

Lars Navér1, Margareta Eriksson, Uwe Ewald, Annika Linde, Magnus Lindroth, Jens Schollin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11838073

Source DB:  PubMed          Journal:  Lakartidningen        ISSN： 0023-7205


× No keyword cloud information.
  2 in total

Review 1.  Palivizumab for preventing severe respiratory syncytial virus (RSV) infection in children.

Authors:  Luis Garegnani; Lea Styrmisdóttir; Pablo Roson Rodriguez; Camila Micaela Escobar Liquitay; Ignacio Esteban; Juan Va Franco
Journal:  Cochrane Database Syst Rev       Date:  2021-11-16

2.  Use of palivizumab is underestimated in the Swedish Prescribed Drug Register - implications for register-based drug studies.

Authors:  Marie Linder; Camilla Byström; Helle Kieler; Gunnar Bergman; Ann Haerskjold
Journal:  Clin Epidemiol       Date:  2014-12-29       Impact factor: 4.790
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.